EnBio Holdings, Inc. ( (JP:6092) ) just unveiled an announcement.
EnBio Holdings, Inc. reported consolidated financial results for the nine months ending December 31, 2024, showing a significant increase in net sales by 17.3% and operating profit by 78.7% compared to the previous year. The results indicate a robust financial performance with an improved equity-to-asset ratio, reflecting the company’s strengthened position in the market.
More about EnBio Holdings, Inc.
EnBio Holdings, Inc. is a company listed on the Tokyo Stock Exchange, primarily engaged in providing services and products within its industry focus.
YTD Price Performance: 2.69%
Average Trading Volume: 9,701
Technical Sentiment Consensus Rating: Hold
Current Market Cap: Yen4.97B
Find detailed analytics on 6092 stock on TipRanks’ Stock Analysis page.